371 related articles for article (PubMed ID: 27514598)
1. Pulmonary Capillary Hemangiomatosis and Pulmonary Veno-occlusive Disease.
Chaisson NF; Dodson MW; Elliott CG
Clin Chest Med; 2016 Sep; 37(3):523-34. PubMed ID: 27514598
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary capillary hemangiomatosis in Chinese patients without EIF2AK4 mutations.
Li Y; Gu Y; Hong C; Deng Y; Chen Z; Jiang J
Pathol Res Pract; 2020 Sep; 216(9):153100. PubMed ID: 32825965
[TBL] [Abstract][Full Text] [Related]
3. Clinical phenotypes and outcomes of heritable and sporadic pulmonary veno-occlusive disease: a population-based study.
Montani D; Girerd B; Jaïs X; Levy M; Amar D; Savale L; Dorfmüller P; Seferian A; Lau EM; Eyries M; Le Pavec J; Parent F; Bonnet D; Soubrier F; Fadel E; Sitbon O; Simonneau G; Humbert M
Lancet Respir Med; 2017 Feb; 5(2):125-134. PubMed ID: 28087362
[TBL] [Abstract][Full Text] [Related]
4. Genetics of pulmonary hypertension in the clinic.
Girerd B; Lau E; Montani D; Humbert M
Curr Opin Pulm Med; 2017 Sep; 23(5):386-391. PubMed ID: 28661905
[TBL] [Abstract][Full Text] [Related]
5. Different sizes of centrilobular ground-glass opacities in chest high-resolution computed tomography of patients with pulmonary veno-occlusive disease and patients with pulmonary capillary hemangiomatosis.
Miura A; Akagi S; Nakamura K; Ohta-Ogo K; Hashimoto K; Nagase S; Kohno K; Kusano K; Ogawa A; Matsubara H; Toyooka S; Oto T; Ohtsuka A; Ohe T; Ito H
Cardiovasc Pathol; 2013; 22(4):287-93. PubMed ID: 23312620
[TBL] [Abstract][Full Text] [Related]
6. Clinical prediction score for identifying patients with pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis.
Ogawa A; Takahashi Y; Matsubara H
J Cardiol; 2018 Sep; 72(3):255-260. PubMed ID: 29548663
[TBL] [Abstract][Full Text] [Related]
7. [Other causes of pulmonary arterial hypertension: pulmonary veno-occlusive disease, pulmonary capillary hemangiomatosis, porto-pulmonary hypertension, HIV- associated pulmonary arterial hypertension].
Karakurt Z
Anadolu Kardiyol Derg; 2010 Aug; 10 Suppl 1():63-8. PubMed ID: 20819769
[TBL] [Abstract][Full Text] [Related]
8. Identification of a Novel EIF2AK Variant and Genetics-Assisted Approach to Diagnosis of Pulmonary Capillary Hemangiomatosis.
Kimmig LM; Stutz MR; Husain AN; Bag R
Lung; 2022 Apr; 200(2):217-219. PubMed ID: 35253092
[TBL] [Abstract][Full Text] [Related]
9. [Pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis: A case report and literature review].
Xiong X; Zhu T; Li J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 May; 43(5):571-576. PubMed ID: 29886475
[TBL] [Abstract][Full Text] [Related]
10. [Clinical and imaging features of pulmonary veno-occlusive disease and pulmonary capillary hemangioma].
Zhao QH; Wu WH; Gong SG; Jiang R; He J; Luo CJ; Qiu HL; Li JL; Liu JM; Wang L
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Jan; 41(1):41-46. PubMed ID: 29343015
[No Abstract] [Full Text] [Related]
11. Clinical features of canine pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.
Reinero CR; Jutkowitz LA; Nelson N; Masseau I; Jennings S; Williams K
J Vet Intern Med; 2019 Jan; 33(1):114-123. PubMed ID: 30499214
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of long-term imatinib therapy for patients with pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.
Ogawa A; Miyaji K; Matsubara H
Respir Med; 2017 Oct; 131():215-219. PubMed ID: 28947033
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary veno-occlusive disease: pathogenesis, risk factors, clinical features and diagnostic algorithm - state of the art.
Szturmowicz M; Kacprzak A; Szołkowska M; Burakowska B; Szczepulska E; Kuś J
Adv Respir Med; 2018; 86(3):. PubMed ID: 29960280
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary capillary haemangiomatosis: a distinct entity?
Weatherald J; Dorfmüller P; Perros F; Ghigna MR; Girerd B; Humbert M; Montani D
Eur Respir Rev; 2020 Jun; 29(156):. PubMed ID: 32461209
[TBL] [Abstract][Full Text] [Related]
15. From the Archives of the AFIP: pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.
Frazier AA; Franks TJ; Mohammed TL; Ozbudak IH; Galvin JR
Radiographics; 2007; 27(3):867-82. PubMed ID: 17495297
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: a clinicopathologic study of 35 cases.
Lantuéjoul S; Sheppard MN; Corrin B; Burke MM; Nicholson AG
Am J Surg Pathol; 2006 Jul; 30(7):850-7. PubMed ID: 16819327
[TBL] [Abstract][Full Text] [Related]
17. Safety and efficacy of epoprostenol therapy in pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis.
Ogawa A; Miyaji K; Yamadori I; Shinno Y; Miura A; Kusano KF; Ito H; Date H; Matsubara H
Circ J; 2012; 76(7):1729-36. PubMed ID: 22481098
[TBL] [Abstract][Full Text] [Related]
18. Use of vasodilators for the treatment of pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis: A systematic review.
Ogawa A; Sakao S; Tanabe N; Matsubara H; Tatsumi K
Respir Investig; 2019 Mar; 57(2):183-190. PubMed ID: 30473253
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary veno-occlusive disease.
Montani D; Lau EM; Dorfmüller P; Girerd B; Jaïs X; Savale L; Perros F; Nossent E; Garcia G; Parent F; Fadel E; Soubrier F; Sitbon O; Simonneau G; Humbert M
Eur Respir J; 2016 May; 47(5):1518-34. PubMed ID: 27009171
[TBL] [Abstract][Full Text] [Related]
20. Natural History over 8 Years of Pulmonary Vascular Disease in a Patient Carrying Biallelic EIF2AK4 Mutations.
Montani D; Dorfmüller P; Girerd B; Le Pavec J; Fadel E; Simonneau G; Sitbon O; Humbert M
Am J Respir Crit Care Med; 2018 Aug; 198(4):537-541. PubMed ID: 29702008
[No Abstract] [Full Text] [Related]
[Next] [New Search]
